Raymond James Financial’s PLDT PHI Stock Holding History

Raymond James Financial’s Portfolio PHI Stock Details PHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-500	Closed	-$10.9K	–	6252
2025 Q2	$10.9K	Buy	+500	New	+$11.3K	﹤0.01%	5892

Other funds holding PHI

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Vident Advisory Alpharetta, Georgia $11.7B AUM 37.32% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial's PHI Position: Q3 2025 in Review

Raymond James Financial sold out of PLDT (PHI) in Q3 2025, closing a stake of 500 shares — an estimated $10.9K sold.

Raymond James Financial first reported a position in PHI in Q2 2025 and held it in 1 quarter. The position peaked at $10.9K in Q2 2025. 79 funds tracked by Wall St. Rank hold PHI as of Q3 2025.

Raymond James Financial reported no remaining PLDT position as of Q3 2025 after selling out during the quarter.
Raymond James Financial sold 500 PLDT shares in Q3 2025, an estimated $10.9K.
Raymond James Financial first reported a position in PLDT in Q2 2025 and held it in 1 quarter.
Raymond James Financial's PLDT position peaked at $10.9K in Q2 2025.
79 funds tracked by Wall St. Rank held PLDT as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.